Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Primary Cells Market – Top Players and Growth Strategies

 



(Medical-NewsWire.com, May 15, 2019 ) According to research report the pimary cells market is expected to reach USD 1,107.3 million by 2023 from USD 736.4 million in 2018, at a CAGR of 8.5%. Factors driving the growth of this market include the increasing adoption of primary cell over cell lines, increasing R&D activities for the development of new cancer therapies, and increasing collaborations & acquisitions.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=32854960
The primary cells market is consolidated in nature, with a few number of players offering variety of products. The key players in the market are Thermo Fisher Scientific (US), Merck KGaA (Germany), Lonza (Switzerland), Cell Biologics (US), PromoCell (Germany), ZenBio (US), STEMCELL Technologies (US), AllCells (US), American Type Culture Collection (US), and Axol Biosciences (UK).
Most companies in the primary cells market adopted expansions and acquisitions as the key business growth strategy. These strategies accounted for the largest share of the overall growth strategies mapped from 2015 to 2018.
Thermo Fisher Scientific (US)
Thermo Fisher Scientific held the leading position in the primary cells market in 2017. Due to its well-established product portfolio, the company maintained its leading position in the primary cells market. The company adopted acquisitions as a key strategy in order to strengthen its position as well as expand its product portfolio. For instance, in 2016, the company acquired MTI-GlobalStem (US) in order to increase and expand its primary cells portfolio.
Merck KGaA (Germany)
In 2017, Merck KGaA ranked second in the primary cells market. The company offers a wide range of products in this market. The company adopted both inorganic growth strategies in order to increase its dominance in this market. The company is highly focused on the Asia Pacific region and investments in countries like China, India, and South Korea. For instance, the company acquired Sigma-Aldrich (US) in 2015, in order to increase and expand its primary cells portfolio.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32854960
Lonza (Switzerland)
Lonza is engaged in providing chemical and biotechnology ingredients and custom manufacturing services to pharmaceutical, healthcare, and life science industries. The company operates through two divisions, namely, Specialty Ingredients and Pharma & Biotech. Through its Pharma & Biotech segment, the company offers human and animal primary cells. The company adopted product launches as a key strategy in order to strengthen its position as well as expand its product portfolio. For instance, in 2018, Lonza expanded its primary cells portfolio and added hepatic stellate cells, Kupffer cells, and liver-derived endothelial cells to its hepatocytes portfolio.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter@marketsandmarkets.com

MarketsandMarkets™

Mr. Shelly Singh

1-888-600-6441

raviraj.tak@marketsandmarkets.com

Source: EmailWire.Com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News

[CaRP] XML error: Mismatched tag at line 14 - This appears to be an HTML webpage, not a feed.

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC